John Porter

John Porter Advocating science from inside the House By Andrea Gawrylewski © Jordan Domont In 1995 when the Republicans took over the US House of Representatives, times were tight for the Appropriations Subcommittee for Labor, Health and Human Services, and Education, which allocates funds to the National Institutes of Health. Under a new budget resolution, the House budget committee told John Porter, then subcommittee chair, he needed to shave

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Andrea Gawrylewski

In 1995 when the Republicans took over the US House of Representatives, times were tight for the Appropriations Subcommittee for Labor, Health and Human Services, and Education, which allocates funds to the National Institutes of Health. Under a new budget resolution, the House budget committee told John Porter, then subcommittee chair, he needed to shave 5% from the National Institutes of Health budget each year for the next five years. "I thought it was insane," Porter recalls one June afternoon from behind his imposing mahogany desk at Hogan and Hartson, a law firm in Washington, DC.

He quickly gathered a group of 10 Nobel laureates, CEOs of pharmaceutical companies, and members of the Federation of American Scientists for Biomedical Research to convince Newt Gingrich, Speaker of the House, to stop cutting the NIH budget and instead to give the agency a boost. "Newt gave us one hour, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio